{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-022668","form_type":"8-K","ticker":"ZVRA","cik":"0001434647","company_name":"ZEVRA THERAPEUTICS, INC.","filed_at":"2024-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.051810+00:00","generated_at":"2026-05-31T21:03:56.989347+00:00","sec_items":["1.01","1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Zevra Therapeutics enters $75M at-the-market equity distribution agreement with Citizens JMP Securities","bullets":["ATM facility allows sale of up to $75M in common stock at company's discretion.","Sales agent receives 3% commission on gross proceeds; shares sold under existing shelf registration.","Prior equity distribution agreement with Citizens JMP and RBC Capital terminated effective July 12, 2024.","Company is not obligated to make any sales under the new agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-022668","json":"https://secwatch.observer/filing/0001437749-24-022668.json","markdown":"https://secwatch.observer/filing/0001437749-24-022668.md","text":"https://secwatch.observer/filing/0001437749-24-022668.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434647/000143774924022668/0001437749-24-022668-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434647/000143774924022668/zvra20240711_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T21:03:56.989347+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}